STOCK TITAN

[SCHEDULE 13G/A] Neuronetics, Inc. Amended Passive Investment Disclosure

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Investor Jorey Chernett filed an amended Schedule 13G reporting his beneficial ownership in Neuronetics, Inc. common stock. He reports holding 6,827,031 shares, with sole power to vote and dispose of all of these shares and no shared voting or dispositive power.

This stake exceeds the 5% threshold that requires public disclosure but is certified as not intended to change or influence control of Neuronetics. The filing lists Chernett as a U.S. individual investor and indicates no group, subsidiaries, or other persons on whose behalf the shares are held.

Positive

  • None.

Negative

  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G



Chernett Jorey
Signature:/s/Jorey Chernett
Name/Title:Individual
Date:02/04/2026
Neuronetics

NASDAQ:STIM

STIM Rankings

STIM Latest News

STIM Latest SEC Filings

STIM Stock Data

97.25M
36.74M
9.44%
59.08%
8.87%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
MALVERN